Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Wu, Yi-Long"" wg kryterium: Autor


Czasopismo naukowe
Tytuł:
Impact of preoperative [F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study
Autorzy:
Lin, Jun-Tao
Li, Xiang-Meng
Zhong, Wen-Zhao
Hou, Qing-Yi
Liu, Chun-Ling
Yu, Xin-Yue
Ye, Kai-Yan
Cheng, Yi-Lu
Du, Jia-Yu
Sun, Yun-Qing
Zhang, Fu-Gui
Yan, Hong-Hong
Liao, Ri-Qiang
Dong, Song
Jiang, Ben-Yuan
Liu, Si-Yang
Wu, Yi-LongAff1, IDs1214902301888z_cor17
Yang, Xue-NingAff1, IDs1214902301888z_cor18
Pokaż więcej
Źródło:
Annals of Nuclear Medicine. 38(3):188-198
Czasopismo naukowe
Tytuł:
A novel image deep learning–based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign
Autorzy:
Yang, XiongwenAff1, Aff2
Chu, Xiang-PengAff1, Aff2
Huang, Shaohong
Xiao, Yi
Li, DantongAff4, Aff5, Aff6
Su, Xiaoyang
Qi, Yi-fanAff1, Aff2
Qiu, Zhen-binAff1, Aff2
Wang, Yanqing
Tang, Wen-Fang
Wu, Yi-Long
Zhu, QikuiAff10, IDs00330023100262_cor12
Liang, HuiyingAff4, Aff5, Aff6, IDs00330023100262_cor13
Zhong, Wen-ZhaoAff1, Aff2, IDs00330023100262_cor14
Pokaż więcej
Źródło:
European Radiology. 34(3):2048-2061
Czasopismo naukowe
Tytuł:
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Autorzy:
Maggie Liu, Si-Yang
Huang, Jie
Deng, Jia-Yi
Xu, Chong-Rui
Yan, Hong-Hong
Yang, Ming-Yi
Li, Yang-Si
Ke, E-E
Zheng, Ming-Ying
Wang, Zhen
Lin, Jia-Xin
Gan, Bin
Zhang, Xu-Chao
Chen, Hua-Jun
Wang, Bin-Chao
Tu, Hai-Yan
Yang, Jin-Ji
Zhong, Wen-Zhao
Li, Yangqiu
Zhou, Qing
Wu, Yi-Long
Pokaż więcej
Źródło:
In Science Bulletin 26 February 2024 69(4):535-543
Czasopismo naukowe
Tytuł:
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis
Autorzy:
Wang, Jie
Wu, Yi-Long
Lu, Shun
Wang, Qun
Li, Shanqing
Zhong, Wen-Zhao
Wang, Qiming
Li, Wei
Wang, Buhai
Chen, Jun
Cheng, Ying
Duan, Hongbing
Li, Gaofeng
Shan, Li
Liu, Yangbo
Liu, Jing
Huang, Xiangning
Bolanos, Ana
He, Jie
Pokaż więcej
Źródło:
In JTO Clinical and Research Reports February 2024 5(2)
Czasopismo naukowe
Tytuł:
Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study
Autorzy:
Zhou, Qing
Zhang, He-Long
Jiang, Li-Yan
Shi, Yuan-Kai
Chen, Yuan
Yu, Jin-Ming
Zhou, Cai-Cun
He, Yong
Hu, Yan-Ping
Liang, Zong-An
Pan, Yue-Yin
Zhuo, Wen-Lei
Song, Yong
Wu, Gang
Chen, Gong-Yan
Lu, You
Zhang, Cui-Ying
Zhang, Yi-Ping
Cheng, Ying
Lu, Shun
Wang, Chang-Li
Zhou, Jian-Ying
Liu, Yun-Peng
He, Jian-Xing
Wang, Jie
Wu, Yi-LongAff1, IDs00432023049238_cor26
Pokaż więcej
Źródło:
Journal of Cancer Research and Clinical Oncology. 149(12):10771-10780
Czasopismo naukowe
Tytuł:
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study
Autorzy:
Liu, Si-Yang
Dong, Song
Yang, Xue-Ning
Liao, Ri-Qiang
Jiang, Ben-Yuan
Wang, Qun
Ben, Xiao-Song
Qiao, Gui-Bin
Lin, Jun-Tao
Yan, Hong-Hong
Yan, Li-Xu
Nie, Qiang
Tu, Hai-Yan
Wang, Bin-Chao
Yang, Jin-Ji
Zhou, Qing
Li, Hong-RuiAff5, Aff6
Liu, KeAff5, Aff6
Wu, WendyAff5, Aff6
Liu, Si-Yang MaggieAff7, Aff8
Zhong, Wen-ZhaoAff1, IDs41392023017004_cor21
Wu, Yi-LongAff1, IDs41392023017004_cor22
Pokaż więcej
Źródło:
Signal Transduction and Targeted Therapy. 8(1)
Czasopismo naukowe
Tytuł:
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
Autorzy:
Shi, JianxinAff1, IDs4146702338196z_cor1
Shiraishi, Kouya
Choi, Jiyeon
Matsuo, Keitaro
Chen, Tzu-Yu
Dai, JunchengAff5, Aff6
Hung, Rayjean J.
Chen, Kexin
Shu, Xiao-Ou
Kim, Young Tae
Landi, Maria Teresa
Lin, Dongxin
Zheng, Wei
Yin, Zhihua
Zhou, Baosen
Song, Bao
Wang, JiucunAff15, Aff16
Seow, Wei JieAff1, Aff17, Aff18
Song, Lei
Chang, I-Shou
Hu, Wei
Chien, Li-Hsin
Cai, Qiuyin
Hong, Yun-Chul
Kim, Hee Nam
Wu, Yi-Long
Wong, Maria Pik
Richardson, Brian DouglasAff1, Aff24
Funderburk, Karen M.
Li, ShilanAff1, Aff25
Zhang, Tongwu
Breeze, Charles
Wang, Zhaoming
Blechter, Batel
Bassig, Bryan A.
Kim, Jin Hee
Albanes, Demetrius
Wong, Jason Y. Y.
Shin, Min-Ho
Chung, Lap Ping
Yang, Yang
An, She-Juan
Zheng, Hong
Yatabe, Yasushi
Zhang, Xu-Chao
Kim, Young-ChulAff30, Aff31
Caporaso, Neil E.
Chang, Jiang
Ho, James Chung Man
Kubo, Michiaki
Daigo, YataroAff35, Aff36
Song, Minsun
Momozawa, Yukihide
Kamatani, Yoichiro
Kobayashi, Masashi
Okubo, Kenichi
Honda, Takayuki
Hosgood, Dean H.
Kunitoh, Hideo
Patel, Harsh
Watanabe, Shun-ichi
Miyagi, Yohei
Nakayama, Haruhiko
Matsumoto, Shingo
Horinouchi, Hidehito
Tsuboi, Masahiro
Hamamoto, Ryuji
Goto, Koichi
Ohe, Yuichiro
Takahashi, Atsushi
Goto, Akiteru
Minamiya, Yoshihiro
Hara, Megumi
Nishida, Yuichiro
Takeuchi, Kenji
Wakai, Kenji
Matsuda, Koichi
Murakami, Yoshinori
Shimizu, Kimihiro
Suzuki, Hiroyuki
Saito, Motonobu
Ohtaki, Yoichi
Tanaka, Kazumi
Wu, Tangchun
Wei, Fusheng
Dai, Hongji
Machiela, Mitchell J.
Su, Jian
Kim, Yeul Hong
Oh, In-JaeAff30, Aff31
Lee, Victor Ho Fun
Chang, Gee-ChenAff63, Aff64, Aff65, Aff66
Tsai, Ying-HuangAff67, Aff68
Chen, Kuan-Yu
Huang, Ming-Shyan
Su, Wu-Chou
Chen, Yuh-Min
Seow, Adeline
Park, Jae Yong
Kweon, Sun-SeogAff21, Aff74
Chen, Kun-Chieh
Gao, Yu-Tang
Qian, Biyun
Wu, Chen
Lu, DaruAff15, Aff16
Liu, JianjunAff76, Aff77
Schwartz, Ann G.
Houlston, Richard
Spitz, Margaret R.
Gorlov, Ivan P.
Wu, Xifeng
Yang, Ping
Lam, Stephen
Tardon, Adonina
Chen, Chu
Bojesen, Stig E.Aff86, Aff87
Johansson, Mattias
Risch, AngelaAff89, Aff90, Aff91
Bickeböller, Heike
Ji, Bu-Tian
Wichmann, H-ErichAff93, Aff94, Aff95
Christiani, David C.
Rennert, Gadi
Arnold, Susanne
Brennan, Paul
McKay, James
Field, John K.
Shete, Sanjay S.
Le Marchand, Loic
Liu, Geoffrey
Andrew, Angeline
Kiemeney, Lambertus A.
Zienolddiny-Narui, Shan
Grankvist, Kjell
Johansson, Mikael
Cox, Angela
Taylor, Fiona
Yuan, Jian-Min
Lazarus, Philip
Schabath, Matthew B.
Aldrich, Melinda C.
Jeon, Hyo-Sung
Jiang, Shih Sheng
Sung, Jae Sook
Chen, Chung-Hsing
Hsiao, Chin-Fu
Jung, Yoo Jin
Guo, Huan
Hu, Zhibin
Burdett, LaurieAff1, Aff116
Yeager, MeredithAff1, Aff116
Hutchinson, AmyAff1, Aff116
Hicks, BelyndaAff1, Aff116
Liu, JiaAff1, Aff116
Zhu, BinAff1, Aff116
Berndt, Sonja I.
Wu, Wei
Wang, JunwenAff117, Aff118
Li, Yuqing
Choi, Jin Eun
Park, Kyong Hwa
Sung, Sook Whan
Liu, Li
Kang, Chang Hyun
Wang, Wen-Chang
Xu, Jun
Guan, PengAff12, Aff124
Tan, Wen
Yu, Chong-Jen
Yang, Gong
Sihoe, Alan Dart Loon
Chen, Ying
Choi, Yi Young
Kim, Jun Suk
Yoon, Ho-Il
Park, In Kyu
Xu, Ping
He, Qincheng
Wang, Chih-Liang
Hung, Hsiao-Han
Vermeulen, Roel C. H.
Cheng, Iona
Wu, JunjieAff15, Aff16
Lim, Wei-Yen
Tsai, Fang-Yu
Chan, John K. C.
Li, Jihua
Chen, HongyanAff15, Aff16
Lin, Hsien-Chih
Jin, LiAff15, Aff16
Liu, Jie
Sawada, Norie
Yamaji, Taiki
Wyatt, KathleenAff1, Aff116
Li, Shengchao A.Aff1, Aff116
Ma, HongxiaAff5, Aff6
Zhu, MengAff5, Aff6
Wang, Zhehai
Cheng, Sensen
Li, XuelianAff12, Aff124
Ren, YangwuAff12, Aff124
Chao, Ann
Iwasaki, MotokiAff135, Aff136
Zhu, Junjie
Jiang, Gening
Fei, Ke
Wu, Guoping
Chen, Chih-YiAff138, Aff139
Chen, Chien-Jen
Yang, Pan-Chyr
Yu, Jinming
Stevens, Victoria L.
Fraumeni, Jr, Joseph F.
Chatterjee, NilanjanAff1, Aff143, Aff144
Gorlova, Olga Y.Aff80, Aff145
Hsiung, Chao Agnes
Amos, Christopher I.Aff80, Aff145
Shen, HongbingAff5, Aff6
Chanock, Stephen J.
Rothman, Nathaniel
Kohno, Takashi
Lan, QingAff1, IDs4146702338196z_cor222
Pokaż więcej
Źródło:
Nature Communications. 14(1)
Czasopismo naukowe
Tytuł:
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors
Autorzy:
Ye, Dingwei
Desai, Jayesh
Shi, Jingwen
Liu, Si-Yang Maggie
Shen, Wei
Liu, Tengfei
Shi, Yang
Wang, Dan
Liang, Liang
Yang, Silu
Ma, Xiaopeng
Jin, Wei
Zhang, Pei
Huang, Ruiqi
Shen, Zhirong
Zhang, YunAff3, IDs4036402300465w_cor16
Wu, Yi-LongAff6, IDs4036402300465w_cor17
Pokaż więcej
Źródło:
Biomarker Research. 11(1)
Czasopismo naukowe
Tytuł:
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer
Autorzy:
Zhou, JiAff1, Aff2
Zhang, Xu-Chao
Xue, Shan
Dai, MengdiAff1, Aff2
Wang, Yueliang
Peng, Xia
Chen, Jianjiao
Wang, Xinyi
Shen, Yanyan
Qin, Hui
Chen, Bi
Zheng, Yu
Gao, Xiwen
Xie, ZuoquanAff1, Aff2
Ding, JianAff1, Aff2, Aff8
Jiang, HandongAff4, IDs4139202301403w_cor16
Wu, Yi-LongAff3, IDs4139202301403w_cor17
Geng, MeiyuAff1, Aff2, Aff8, IDs4139202301403w_cor18
Ai, JingAff1, Aff2, Aff8, IDs4139202301403w_cor19
Pokaż więcej
Źródło:
Signal Transduction and Targeted Therapy. 8(1)
Czasopismo naukowe
Tytuł:
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial
Autorzy:
Zhong, Wen-Zhao
Yan, Hong-Hong
Chen, Ke-Neng
Chen, Chun
Gu, Chun-Dong
Wang, Jun
Yang, Xue-Ning
Mao, Wei-Min
Wang, Qun
Qiao, Gui-BinAff1, Aff8
Cheng, Ying
Xu, Lin
Wang, Chang-Li
Chen, Ming-Wei
Kang, Xiao-Zheng
Yan, Wan-Pu
Liao, Ri-Qiang
Yang, Jin-Ji
Zhang, Xu-Chao
Liu, Si-Yang
Zhou, Qing
Wu, Yi-LongAff1, IDs41392022012863_cor22
Pokaż więcej
Źródło:
Signal Transduction and Targeted Therapy. 8(1)
Czasopismo naukowe
Tytuł:
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial
Autorzy:
Chmielecki, Juliann
Mok, Tony
Wu, Yi-Long
Han, Ji-Youn
Ahn, Myung-Ju
Ramalingam, Suresh S.
John, Thomas
Okamoto, Isamu
Yang, James Chih-Hsin
Shepherd, Frances A.
Bulusu, Krishna C.
Laus, GianlucaAff11, Aff14
Collins, BarbaraAff12, Aff15
Barrett, J. Carl
Hartmaier, Ryan J.
Papadimitrakopoulou, VassilikiAff13, Aff16, IDs4146702335962x_cor16
Pokaż więcej
Źródło:
Nature Communications. 14(1)
Czasopismo naukowe
Tytuł:
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
Autorzy:
Maggie Liu, Si-Yang
Dong, Xiao-Rong
Wang, Zhen
Du, Yingying
Cui, Jiu-Wei
Chu, Qian
Xu, Bing-Fei
Zheng, Ming-Ying
Deng, Jia-Yi
Lu, Chang
Wei, Xue-Wu
Li, Yang-Si
Zheng, Mei-Mei
Yang, Ming-Yi
Huang, Jie
Li, Anna
Bai, Xiao-Yan
Sun, Yue-Li
Xu, Chong-Rui
Wang, Bin-Chao
Chen, Hua-Jun
Yang, Jin-Ji
Yan, Hong-Hong
Zhong, Wen-Zhao
Zhou, Qing
Wu, Yi-Long
Pokaż więcej
Źródło:
In eClinicalMedicine October 2023 64
Czasopismo naukowe
Tytuł:
ASO Visual Abstract: Expression Changes in Programmed Death Ligand 1 from Precancerous Lesions to Invasive Adenocarcinoma in Subcentimeter Pulmonary Nodules—A Large Study of 2022 Cases in China
Autorzy:
Yang, XiongwenAff1, Aff2
Xiao, Yi
Hu, Hao
Qiu, Zhen-binAff1, Aff2
Qi, Yi-fanAff1, Aff2
Wang, Meng-min
Wu, Yi-Long
Zhong, Wen-ZhaoAff1, Aff2, IDs10434023142848_cor8
Pokaż więcej
Źródło:
Annals of Surgical Oncology. 31(1):245-246
Czasopismo naukowe
Tytuł:
Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
Autorzy:
Liu, Si-Yang
Chen, Qixun
Zhou, Chengzhi
Zhang, Huizhong
Li, Wen
Chen, Jianhua
Hu, Jian
Wu, Lin
Chen, Qunqing
Dai, Qiangsheng
Shan, Jian-Zhen
Xu, Fei
Liu, Si-Yang MaggieAff13, Aff14, IDs00262023034128_cor13
Wu, Yi-LongAff1, IDs00262023034128_cor14
Pokaż więcej
Źródło:
Cancer Immunology, Immunotherapy. 72(7):2257-2265
Czasopismo naukowe
Tytuł:
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer
Autorzy:
Verhoek, AndreAff1, IDs41669023003960_cor1
Cheema, Parneet
Melosky, Barbara
Samson, Benoit
Shepherd, Frances A.
de Marinis, Filippo
John, Thomas
Wu, Yi-Long
Heeg, Bart
Van Dalfsen, Nadia
Bracke, Benjamin
Miranda, Miguel
Shaw, Simon
Moldaver, Daniel
Pokaż więcej
Źródło:
PharmacoEconomics - Open: Healthcare Interventions and Outcomes. 7(3):455-467
Czasopismo naukowe
Tytuł:
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial
Autorzy:
Chen, Cunte
Liu, Siyang MaggieAff1, Aff2, Aff3
Chen, Yedan
Ou, Qiuxiang
Bao, Hua
Xu, Ling
Zhang, Yikai
Zhang, Jia-Tao
Zhong, Wenzhao
Zhou, Qing
Yang, Xue-Ning
Shao, YangAff4, Aff6
Wu, Yi-LongAff5, IDs00262022033301_cor13
Liu, Si-YangAff5, IDs00262022033301_cor14
Li, YangqiuAff1, Aff2, IDs00262022033301_cor15
Pokaż więcej
Źródło:
Cancer Immunology, Immunotherapy. 72(5):1261-1272
Czasopismo naukowe
Tytuł:
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Autorzy:
Wang, Han-Min
Zhang, Chan-Yuan
Peng, Kai-Cheng
Chen, Ze-Xin
Su, Jun-Wei
Li, Yu-Fa
Li, Wen-Feng
Gao, Qing-Yun
Zhang, Shi-Ling
Chen, Yu-Qing
Zhou, Qing
Xu, Cong
Xu, Chong-Rui
Wang, Zhen
Su, Jian
Yan, Hong-Hong
Zhang, Xu-Chao
Chen, Hua-Jun
Wu, Yi-Long
Yang, Jin-Ji
Pokaż więcej
Źródło:
In Cell Reports Medicine 21 February 2023 4(2)
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies